Top Markets
Coin of the day
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA
Rankning i aktier #32448
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on... Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
Aktiekurs
$1.11
Senast synkroniserad: 2026-08-17
Marknadsvärde
$10.06M
Förändring (1 dag)
1.38%
Förändring (1 år)
-55.98%
Land
US
Handel Lisata Therapeutics, Inc. (LSTA)

Kategori

Historik för aktiesplit för Lisata Therapeutics, Inc. (LSTA)
Aktien Lisata Therapeutics, Inc. (symbol: LSTA) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 18, 2026.
En LSTA-aktie köpt före Aug 18, 2026 motsvarar nu 0 LSTA-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR